EP0035119A3 - Polyether compounds and their manufacture, resultant composition and the use of these products as medicaments or growth promoting agents in ruminants - Google Patents
Polyether compounds and their manufacture, resultant composition and the use of these products as medicaments or growth promoting agents in ruminants Download PDFInfo
- Publication number
- EP0035119A3 EP0035119A3 EP81100651A EP81100651A EP0035119A3 EP 0035119 A3 EP0035119 A3 EP 0035119A3 EP 81100651 A EP81100651 A EP 81100651A EP 81100651 A EP81100651 A EP 81100651A EP 0035119 A3 EP0035119 A3 EP 0035119A3
- Authority
- EP
- European Patent Office
- Prior art keywords
- ruminants
- medicaments
- manufacture
- products
- growth promoting
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Granted
Links
Classifications
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12P—FERMENTATION OR ENZYME-USING PROCESSES TO SYNTHESISE A DESIRED CHEMICAL COMPOUND OR COMPOSITION OR TO SEPARATE OPTICAL ISOMERS FROM A RACEMIC MIXTURE
- C12P17/00—Preparation of heterocyclic carbon compounds with only O, N, S, Se or Te as ring hetero atoms
- C12P17/18—Preparation of heterocyclic carbon compounds with only O, N, S, Se or Te as ring hetero atoms containing at least two hetero rings condensed among themselves or condensed with a common carbocyclic ring system, e.g. rifamycin
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07H—SUGARS; DERIVATIVES THEREOF; NUCLEOSIDES; NUCLEOTIDES; NUCLEIC ACIDS
- C07H19/00—Compounds containing a hetero ring sharing one ring hetero atom with a saccharide radical; Nucleosides; Mononucleotides; Anhydro-derivatives thereof
- C07H19/01—Compounds containing a hetero ring sharing one ring hetero atom with a saccharide radical; Nucleosides; Mononucleotides; Anhydro-derivatives thereof sharing oxygen
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
- A61P1/12—Antidiarrhoeals
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P3/00—Drugs for disorders of the metabolism
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
- A61P31/04—Antibacterial agents
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P33/00—Antiparasitic agents
- A61P33/02—Antiprotozoals, e.g. for leishmaniasis, trichomoniasis, toxoplasmosis
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N1/00—Microorganisms, e.g. protozoa; Compositions thereof; Processes of propagating, maintaining or preserving microorganisms or compositions thereof; Processes of preparing or isolating a composition containing a microorganism; Culture media therefor
- C12N1/20—Bacteria; Culture media therefor
- C12N1/205—Bacterial isolates
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12P—FERMENTATION OR ENZYME-USING PROCESSES TO SYNTHESISE A DESIRED CHEMICAL COMPOUND OR COMPOSITION OR TO SEPARATE OPTICAL ISOMERS FROM A RACEMIC MIXTURE
- C12P19/00—Preparation of compounds containing saccharide radicals
- C12P19/44—Preparation of O-glycosides, e.g. glucosides
- C12P19/60—Preparation of O-glycosides, e.g. glucosides having an oxygen of the saccharide radical directly bound to a non-saccharide heterocyclic ring or a condensed ring system containing a non-saccharide heterocyclic ring, e.g. coumermycin, novobiocin
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12R—INDEXING SCHEME ASSOCIATED WITH SUBCLASSES C12C - C12Q, RELATING TO MICROORGANISMS
- C12R2001/00—Microorganisms ; Processes using microorganisms
- C12R2001/01—Bacteria or Actinomycetales ; using bacteria or Actinomycetales
- C12R2001/365—Nocardia
Landscapes
- Chemical & Material Sciences (AREA)
- Health & Medical Sciences (AREA)
- Organic Chemistry (AREA)
- Life Sciences & Earth Sciences (AREA)
- Engineering & Computer Science (AREA)
- General Health & Medical Sciences (AREA)
- Zoology (AREA)
- Wood Science & Technology (AREA)
- Biotechnology (AREA)
- Genetics & Genomics (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Biochemistry (AREA)
- General Chemical & Material Sciences (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Medicinal Chemistry (AREA)
- General Engineering & Computer Science (AREA)
- Veterinary Medicine (AREA)
- Microbiology (AREA)
- Animal Behavior & Ethology (AREA)
- Public Health (AREA)
- Pharmacology & Pharmacy (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Tropical Medicine & Parasitology (AREA)
- Molecular Biology (AREA)
- Virology (AREA)
- Biomedical Technology (AREA)
- Hematology (AREA)
- Obesity (AREA)
- Diabetes (AREA)
- Oncology (AREA)
- Communicable Diseases (AREA)
- Fodder In General (AREA)
- Preparation Of Compounds By Using Micro-Organisms (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Saccharide Compounds (AREA)
- Micro-Organisms Or Cultivation Processes Thereof (AREA)
- Feed For Specific Animals (AREA)
- Compounds Of Unknown Constitution (AREA)
- Medicines Containing Material From Animals Or Micro-Organisms (AREA)
- Peptides Or Proteins (AREA)
Priority Applications (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
AT81100651T ATE4217T1 (en) | 1980-01-30 | 1981-01-29 | POLYAETHER COMPOUNDS AND THEIR PRODUCTION, RELATIVE PREPARATIONS AND THE USE OF SUCH PRODUCTS AS CURING OR GROWTH PROMOTERS IN RUMINANTS. |
Applications Claiming Priority (2)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
US116696 | 1980-01-30 | ||
US06/116,696 US4278663A (en) | 1980-01-30 | 1980-01-30 | Antibiotic X-14868A, B, C and D |
Publications (3)
Publication Number | Publication Date |
---|---|
EP0035119A2 EP0035119A2 (en) | 1981-09-09 |
EP0035119A3 true EP0035119A3 (en) | 1981-12-16 |
EP0035119B1 EP0035119B1 (en) | 1983-07-20 |
Family
ID=22368677
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
EP81100651A Expired EP0035119B1 (en) | 1980-01-30 | 1981-01-29 | Polyether compounds and their manufacture, resultant composition and the use of these products as medicaments or growth promoting agents in ruminants |
Country Status (22)
Country | Link |
---|---|
US (1) | US4278663A (en) |
EP (1) | EP0035119B1 (en) |
JP (1) | JPS56120696A (en) |
KR (1) | KR840000750B1 (en) |
AR (1) | AR227660A1 (en) |
AT (1) | ATE4217T1 (en) |
AU (1) | AU536300B2 (en) |
CA (1) | CA1160972A (en) |
DE (1) | DE3160616D1 (en) |
DK (1) | DK149639C (en) |
ES (1) | ES8203964A1 (en) |
FI (1) | FI70247C (en) |
GR (1) | GR73021B (en) |
HU (1) | HU187763B (en) |
IE (1) | IE50886B1 (en) |
IL (1) | IL61971A (en) |
MC (1) | MC1364A1 (en) |
NO (1) | NO156612C (en) |
NZ (1) | NZ196099A (en) |
PH (1) | PH16583A (en) |
PT (1) | PT72417B (en) |
ZA (1) | ZA81151B (en) |
Families Citing this family (22)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
JPS577492A (en) | 1980-06-13 | 1982-01-14 | Shionogi & Co Ltd | K-41 derivative |
US4407946A (en) * | 1981-10-22 | 1983-10-04 | American Cyanamid Company | Process for producing antibiotic X-14868A |
CA1198386A (en) * | 1981-10-22 | 1985-12-24 | Donald B. Borders | ANTIBACTERIAL AGENTS LL-C23024.beta. AND IOTA AND MICROORGANISM ACTINOMADURA YUMAENSE NRRL 12515 |
US4510134A (en) * | 1982-05-07 | 1985-04-09 | American Cyanamid Co. | Controlling nematodes in animals and soil with nematocidal antibiotics |
US4565862A (en) * | 1982-11-29 | 1986-01-21 | Hoffmann-La Roche Inc. | Ethers of antibiotic X-14868A |
ZA838562B (en) * | 1982-11-29 | 1984-07-25 | Hoffmann La Roche | Ethers |
US4496549A (en) * | 1983-01-17 | 1985-01-29 | American Cyanamid Company | Treatment of malaria with antibiotics |
US4628046A (en) * | 1983-06-20 | 1986-12-09 | American Cyanamid Company | Antibiotic LL-C23201δ |
GB8417785D0 (en) * | 1984-07-12 | 1984-08-15 | Pfizer Ltd | Polycyclic ether antibiotic |
US4824829A (en) * | 1984-08-15 | 1989-04-25 | American Cyanamid Company | Non-dusting antibiotic, anticoccidial premix compositions and a process for their manufacture |
US4582822A (en) * | 1984-10-09 | 1986-04-15 | Eli Lilly And Company | Antibiotic A80190, pharmaceutical compositions containing same and method of use |
EP0182117B1 (en) * | 1984-11-15 | 1989-10-18 | American Cyanamid Company | Anticoccidial compostions |
US4824863A (en) * | 1985-05-28 | 1989-04-25 | Eli Lilly And Company | Antibiotic A80438 |
GB8618844D0 (en) * | 1986-08-01 | 1986-09-10 | Pfizer Ltd | Polycyclic ether antibiotics |
DE3638445A1 (en) * | 1986-11-11 | 1988-05-26 | Hoechst Ag | COCCIDIOCIDE MEDIUM |
US4816480A (en) * | 1987-05-12 | 1989-03-28 | American Cyanamid Company | Method for the preparation of feed premix in compositions of maduramicin |
DE3884741T2 (en) * | 1987-10-26 | 1994-01-27 | Pfizer | Microbiological process for the preparation of UK-61.689 and microorganisms for use therein. |
US5034224A (en) * | 1989-05-30 | 1991-07-23 | American Cyanamid Company | Method and composition for treating protozoal infections |
US5242814A (en) * | 1989-10-10 | 1993-09-07 | Eli Lilly And Company | Polyether antibiotic |
US5043353A (en) * | 1989-10-10 | 1991-08-27 | Eli Lilly And Company | A80789 polyether antibiotic |
FR2700778B1 (en) * | 1993-01-27 | 1995-04-14 | Agronomique Inst Nat Rech | Selective medium and method for the enumeration of propionic bacteria. |
CN106008625B (en) * | 2016-05-19 | 2018-07-20 | 宁夏泰瑞制药股份有限公司 | A method of preparing Maduramicin Ammonium using Madumycin zymotic fluid |
Family Cites Families (1)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US4138481A (en) * | 1976-06-30 | 1979-02-06 | American Cyanamid Company | Antibiotic BL580Δ and method of use |
-
1980
- 1980-01-30 US US06/116,696 patent/US4278663A/en not_active Expired - Lifetime
-
1981
- 1981-01-09 ZA ZA00810151A patent/ZA81151B/en unknown
- 1981-01-22 DK DK29881A patent/DK149639C/en not_active IP Right Cessation
- 1981-01-23 NZ NZ196099A patent/NZ196099A/en unknown
- 1981-01-23 IL IL61971A patent/IL61971A/en not_active IP Right Cessation
- 1981-01-23 AU AU66572/81A patent/AU536300B2/en not_active Expired
- 1981-01-26 MC MC811496A patent/MC1364A1/en unknown
- 1981-01-28 HU HU81180A patent/HU187763B/en unknown
- 1981-01-28 GR GR63990A patent/GR73021B/el unknown
- 1981-01-28 PH PH25142A patent/PH16583A/en unknown
- 1981-01-29 PT PT72417A patent/PT72417B/en unknown
- 1981-01-29 NO NO810319A patent/NO156612C/en not_active IP Right Cessation
- 1981-01-29 JP JP1219381A patent/JPS56120696A/en active Granted
- 1981-01-29 EP EP81100651A patent/EP0035119B1/en not_active Expired
- 1981-01-29 AT AT81100651T patent/ATE4217T1/en not_active IP Right Cessation
- 1981-01-29 IE IE172/81A patent/IE50886B1/en not_active IP Right Cessation
- 1981-01-29 KR KR1019810000276A patent/KR840000750B1/en active
- 1981-01-29 CA CA000369657A patent/CA1160972A/en not_active Expired
- 1981-01-29 FI FI810252A patent/FI70247C/en not_active IP Right Cessation
- 1981-01-29 AR AR284113A patent/AR227660A1/en active
- 1981-01-29 DE DE8181100651T patent/DE3160616D1/en not_active Expired
- 1981-01-29 ES ES498922A patent/ES8203964A1/en not_active Expired
Non-Patent Citations (1)
Title |
---|
THE JOURNAL OF ANTIBIOTICS, Band 32, Nr. 10, 1979 Seiten 79-96 & Jap. Antibiot. Res. Associat. * |
Also Published As
Publication number | Publication date |
---|---|
JPS56120696A (en) | 1981-09-22 |
DE3160616D1 (en) | 1983-08-25 |
AR227660A1 (en) | 1982-11-30 |
KR840000750B1 (en) | 1984-05-31 |
NO156612B (en) | 1987-07-13 |
ES498922A0 (en) | 1982-05-01 |
EP0035119B1 (en) | 1983-07-20 |
IL61971A0 (en) | 1981-02-27 |
IL61971A (en) | 1984-01-31 |
EP0035119A2 (en) | 1981-09-09 |
IE810172L (en) | 1981-07-30 |
GR73021B (en) | 1984-01-25 |
IE50886B1 (en) | 1986-08-06 |
AU536300B2 (en) | 1984-05-03 |
CA1160972A (en) | 1984-01-24 |
FI810252L (en) | 1981-07-31 |
DK149639B (en) | 1986-08-18 |
ATE4217T1 (en) | 1983-08-15 |
DK29881A (en) | 1981-07-31 |
FI70247C (en) | 1986-09-15 |
JPH0250918B2 (en) | 1990-11-05 |
FI70247B (en) | 1986-02-28 |
US4278663A (en) | 1981-07-14 |
KR830005358A (en) | 1983-08-13 |
NZ196099A (en) | 1984-07-06 |
DK149639C (en) | 1987-02-02 |
PH16583A (en) | 1983-11-22 |
ES8203964A1 (en) | 1982-05-01 |
PT72417A (en) | 1981-02-01 |
PT72417B (en) | 1982-07-26 |
MC1364A1 (en) | 1981-10-23 |
AU6657281A (en) | 1981-08-06 |
NO810319L (en) | 1981-07-31 |
NO156612C (en) | 1987-10-21 |
ZA81151B (en) | 1982-01-27 |
HU187763B (en) | 1986-02-28 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
DE3160616D1 (en) | Polyether compounds and their manufacture, resultant composition and the use of these products as medicaments or growth promoting agents in ruminants | |
DE3170119D1 (en) | Product in powder form for the treatment of wounds, and method for the preparation thereof | |
DE3176086D1 (en) | Mucopolysaccharides having biological properties; their preparation and use as medicines | |
DE3066205D1 (en) | Imidazole-5-acetic acid derivatives, their production and use | |
ZA83743B (en) | Pyrazolooxazines,pyrazolothiazines,and pyrazoloquinolines,process for their preparation and their use as medicaments | |
JPS5791983A (en) | Ranitidine, manufacture and medicinal composition containing same | |
ZA83812B (en) | Water soluble glass articles,their manufacture,and their use in the treatment of ruminant animals | |
JPS57108090A (en) | Novel nortropane and granatane derivatives, manufacture and use as medicine | |
IT1190929B (en) | DIHYDROPYRIDINS WITH POSITIVE INOTROP ACTION, COMPOUNDS, THEIR USE IN MEDICINAL PRODUCTS AND PROCEDURE FOR THEIR PREPARATION | |
PH21847A (en) | Phenalkoxyalkyl-and phenoxyalkyl-substituted oxiranecarboxylic acids,their use and medicaments containing them | |
DE3167679D1 (en) | Pharmaceutical forms, their preparation and compositions containing the same | |
DE3369682D1 (en) | 2-substituted 1-aminoalkyl-1,2,3,4-tetrahydro-beta-carbolines, their preparation and use as medicaments | |
DE3475164D1 (en) | Synergistic pharmaceutical compositions, their production and use | |
EP0133766A3 (en) | Coumarin derivatives, pharmaceutical compositions containing the same, and the use thereof in the treatment of cancer | |
IL66618A0 (en) | Imidazoquinazoline derivatives,their manufacture and pharmaceutical compositions containing them | |
DE3262374D1 (en) | 2-piperazino-pyrimidine derivatives, processes for their preparation, medicaments containing them and their use as intermediates in the manufacture of medicaments | |
IL63524A0 (en) | Imidazoquinazoline derivatives,their manufacture and pharmaceutical compositions containing them | |
IL68118A0 (en) | Phenoxypropyltriazolyl-ketones and-carbinols,their preparation and their use as fungicides | |
IL59566A0 (en) | Polysubstituted diazatricycles,their manufacture and pharmaceutical compositions containing them | |
ZA805390B (en) | Substituted quinolinone-alkanecarboxylic acids, their preparation and use, and medicaments containing them | |
PH22226A (en) | Human endogenous cancer regulatory factor, process for preparing the same and pharmaceutical composition containing the same | |
EP0035945A3 (en) | Acyl guanidines, ureas and substituted ureas, their preparation and their use as medicaments | |
JPS5724339A (en) | Alkoxy-acylcarnitine, manufacture and medicinal composition as effective component thereof | |
ZA845618B (en) | New 1,2-diaryl-3-azolylpropane derivatives,their preparation and their use as agents for the treatment of plants | |
IL72467A0 (en) | New 1,2-diaryl-3-azolylpropane derivatives,their preparation and their use as agents for the treatment of plants |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
PUAI | Public reference made under article 153(3) epc to a published international application that has entered the european phase |
Free format text: ORIGINAL CODE: 0009012 |
|
17P | Request for examination filed |
Effective date: 19810129 |
|
AK | Designated contracting states |
Designated state(s): AT BE CH DE FR GB IT LU NL SE |
|
PUAL | Search report despatched |
Free format text: ORIGINAL CODE: 0009013 |
|
AK | Designated contracting states |
Designated state(s): AT BE CH DE FR GB IT LU NL SE |
|
RHK1 | Main classification (correction) |
Ipc: C07H 17/04 |
|
ITF | It: translation for a ep patent filed |
Owner name: BARZANO' E ZANARDO MILANO S.P.A. |
|
GRAA | (expected) grant |
Free format text: ORIGINAL CODE: 0009210 |
|
AK | Designated contracting states |
Designated state(s): AT BE CH DE FR GB IT LI LU NL SE |
|
REF | Corresponds to: |
Ref document number: 4217 Country of ref document: AT Date of ref document: 19830815 Kind code of ref document: T |
|
REF | Corresponds to: |
Ref document number: 3160616 Country of ref document: DE Date of ref document: 19830825 |
|
ET | Fr: translation filed | ||
KL | Correction list |
Free format text: 83/05 NEUDRUCK |
|
ET1 | Fr: translation filed ** revision of the translation of the patent or the claims | ||
PLBE | No opposition filed within time limit |
Free format text: ORIGINAL CODE: 0009261 |
|
STAA | Information on the status of an ep patent application or granted ep patent |
Free format text: STATUS: NO OPPOSITION FILED WITHIN TIME LIMIT |
|
26N | No opposition filed | ||
ITPR | It: changes in ownership of a european patent |
Owner name: CESSIONE;F. HOFFMANN - LA ROCHE AG |
|
NLS | Nl: assignments of ep-patents |
Owner name: F. HOFFMANN-LA ROCHE AG TE BAZEL, ZWITSERLAND. |
|
REG | Reference to a national code |
Ref country code: FR Ref legal event code: TP |
|
REG | Reference to a national code |
Ref country code: CH Ref legal event code: PUE Owner name: F. HOFFMANN-LA ROCHE AG |
|
REG | Reference to a national code |
Ref country code: GB Ref legal event code: 732 |
|
ITTA | It: last paid annual fee | ||
EPTA | Lu: last paid annual fee | ||
EAL | Se: european patent in force in sweden |
Ref document number: 81100651.9 |
|
PGFP | Annual fee paid to national office [announced via postgrant information from national office to epo] |
Ref country code: DE Payment date: 19991231 Year of fee payment: 20 |
|
PGFP | Annual fee paid to national office [announced via postgrant information from national office to epo] |
Ref country code: SE Payment date: 20000107 Year of fee payment: 20 |
|
PGFP | Annual fee paid to national office [announced via postgrant information from national office to epo] |
Ref country code: AT Payment date: 20000110 Year of fee payment: 20 |
|
PGFP | Annual fee paid to national office [announced via postgrant information from national office to epo] |
Ref country code: FR Payment date: 20000112 Year of fee payment: 20 |
|
PGFP | Annual fee paid to national office [announced via postgrant information from national office to epo] |
Ref country code: LU Payment date: 20000120 Year of fee payment: 20 |
|
PGFP | Annual fee paid to national office [announced via postgrant information from national office to epo] |
Ref country code: GB Payment date: 20000126 Year of fee payment: 20 |
|
PGFP | Annual fee paid to national office [announced via postgrant information from national office to epo] |
Ref country code: CH Payment date: 20000127 Year of fee payment: 20 |
|
PGFP | Annual fee paid to national office [announced via postgrant information from national office to epo] |
Ref country code: NL Payment date: 20000131 Year of fee payment: 20 |
|
PGFP | Annual fee paid to national office [announced via postgrant information from national office to epo] |
Ref country code: BE Payment date: 20000315 Year of fee payment: 20 |
|
BE20 | Be: patent expired |
Free format text: 20010129 F. *HOFFMANN-LA ROCHE A.G. |
|
PG25 | Lapsed in a contracting state [announced via postgrant information from national office to epo] |
Ref country code: LI Free format text: LAPSE BECAUSE OF EXPIRATION OF PROTECTION Effective date: 20010128 Ref country code: GB Free format text: LAPSE BECAUSE OF EXPIRATION OF PROTECTION Effective date: 20010128 Ref country code: CH Free format text: LAPSE BECAUSE OF EXPIRATION OF PROTECTION Effective date: 20010128 |
|
PG25 | Lapsed in a contracting state [announced via postgrant information from national office to epo] |
Ref country code: NL Free format text: LAPSE BECAUSE OF EXPIRATION OF PROTECTION Effective date: 20010129 Ref country code: LU Free format text: LAPSE BECAUSE OF EXPIRATION OF PROTECTION Effective date: 20010129 Ref country code: AT Free format text: LAPSE BECAUSE OF EXPIRATION OF PROTECTION Effective date: 20010129 |
|
PG25 | Lapsed in a contracting state [announced via postgrant information from national office to epo] |
Ref country code: SE Free format text: THE PATENT HAS BEEN ANNULLED BY A DECISION OF A NATIONAL AUTHORITY Effective date: 20010130 |
|
REG | Reference to a national code |
Ref country code: GB Ref legal event code: PE20 Effective date: 20010128 |
|
REG | Reference to a national code |
Ref country code: CH Ref legal event code: PL |
|
EUG | Se: european patent has lapsed |
Ref document number: 81100651.9 |
|
NLV7 | Nl: ceased due to reaching the maximum lifetime of a patent |
Effective date: 20010129 |